Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.91 - $3.35 $170 - $626
-187 Reduced 5.76%
3,061 $5,000
Q3 2023

Nov 14, 2023

BUY
$3.65 - $6.9 $598 - $1,131
164 Added 5.32%
3,248 $12,000
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $427 - $691
122 Added 4.12%
3,084 $16,000
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $2,126 - $4,128
589 Added 24.82%
2,962 $12,000
Q4 2022

Feb 14, 2023

BUY
$3.66 - $6.77 $8,685 - $16,065
2,373 New
2,373 $9,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $47.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.